| First Author | Balka KR | Year | 2020 |
| Journal | Cell Rep | Volume | 31 |
| Issue | 1 | Pages | 107492 |
| PubMed ID | 32268090 | Mgi Jnum | J:314406 |
| Mgi Id | MGI:6715276 | Doi | 10.1016/j.celrep.2020.03.056 |
| Citation | Balka KR, et al. (2020) TBK1 and IKKepsilon Act Redundantly to Mediate STING-Induced NF-kappaB Responses in Myeloid Cells. Cell Rep 31(1):107492 |
| abstractText | Stimulator of Interferon Genes (STING) is a critical component of host innate immune defense but can contribute to chronic autoimmune or autoinflammatory disease. Once activated, the cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) (cGAMP) synthase (cGAS)-STING pathway induces both type I interferon (IFN) expression and nuclear factor-kappaB (NF-kappaB)-mediated cytokine production. Currently, these two signaling arms are thought to be mediated by a single upstream kinase, TANK-binding kinase 1 (TBK1). Here, using genetic and pharmacological approaches, we show that TBK1 alone is dispensable for STING-induced NF-kappaB responses in human and mouse immune cells, as well as in vivo. We further demonstrate that TBK1 acts redundantly with IkappaB kinase epsilon (IKKepsilon) to drive NF-kappaB upon STING activation. Interestingly, we show that activation of IFN regulatory factor 3 (IRF3) is highly dependent on TBK1 kinase activity, whereas NF-kappaB is significantly less sensitive to TBK1/IKKepsilon kinase inhibition. Our work redefines signaling events downstream of cGAS-STING. Our findings further suggest that cGAS-STING will need to be targeted directly to effectively ameliorate the inflammation underpinning disorders associated with STING hyperactivity. |
